Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons.


Journal

Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963

Informations de publication

Date de publication:
May 2020
Historique:
received: 20 09 2019
accepted: 20 01 2020
pubmed: 1 2 2020
medline: 4 2 2021
entrez: 1 2 2020
Statut: ppublish

Résumé

Mutations in the CDKL5 gene, which encodes a serine/threonine kinase, causes a rare encephalopathy, characterized by early-onset epilepsy and severe intellectual disability, named CDKL5 deficiency disorder (CDD). In vitro and in vivo studies in mouse models of Cdkl5 deficiency have highlighted the role of CDKL5 in brain development and, in particular, in the morphogenesis and synaptic connectivity of hippocampal and cortical neurons. Interestingly, Cdkl5 deficiency in mice increases vulnerability to excitotoxic stress in hippocampal neurons. However, the mechanism by which CDKL5 controls neuronal survival is far from being understood. To investigate further the function of CDKL5 and dissect the molecular mechanisms underlying neuronal survival, we generated a human neuronal model of CDKL5 deficiency, using CRISPR/Cas9-mediated genome editing. We demonstrated that CDKL5 deletion in human neuroblastoma SH-SY5Y cells not only impairs neuronal maturation but also reduces cell proliferation and survival, with alterations in the AKT and ERK signaling pathways and an increase in the proapoptotic BAX protein and in DNA damage-associated biomarkers (i.e., γH2AX, RAD50, and PARP1). Furthermore, CDKL5-deficient cells were hypersensitive to DNA damage-associated stress, accumulated more DNA damage foci (γH2AX positive) and were more prone to cell death than the controls. Importantly, increased kainic acid-induced cell death of hippocampal neurons of Cdkl5 KO mice correlated with an increased γH2AX immunostaining. The results suggest a previously unknown role for CDKL5 in DNA damage response that could underlie the pro-survival function of CDKL5.

Identifiants

pubmed: 32002787
doi: 10.1007/s12035-020-01884-8
pii: 10.1007/s12035-020-01884-8
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
H2AX protein, human 0
Histones 0
gamma-H2AX protein, mouse 0
Tretinoin 5688UTC01R
Hydrogen Peroxide BBX060AN9V
Protein Serine-Threonine Kinases EC 2.7.11.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
CDKL5 protein, human EC 2.7.11.22
CDKL5 protein, mouse EC 2.7.11.22
Kainic Acid SIV03811UC

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2244-2262

Commentaires et corrections

Type : ErratumIn

Références

Fehr S, Wilson M, Downs J, Williams S, Murgia A, Sartori S, Vecchi M, Ho G et al (2013) The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur J Hum Genet 21(3):266–273. https://doi.org/10.1038/ejhg.2012.156
doi: 10.1038/ejhg.2012.156 pubmed: 22872100 pmcid: 22872100
Dale T, Downs J, Olson H, Bergin AM, Smith S, Leonard H (2019) Cannabis for refractory epilepsy in children: a review focusing on CDKL5 deficiency disorder. Epilepsy Res 151:31–39. https://doi.org/10.1016/j.eplepsyres.2019.02.001
doi: 10.1016/j.eplepsyres.2019.02.001 pubmed: 30771550 pmcid: 30771550
Montini E, Andolfi G, Caruso A, Buchner G, Walpole SM, Mariani M, Consalez G, Trump D et al (1998) Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region. Genomics 51(3):427–433. https://doi.org/10.1006/geno.1998.5391
doi: 10.1006/geno.1998.5391 pubmed: 9721213 pmcid: 9721213
Lin C, Franco B, Rosner MR (2005) CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. Hum Mol Genet 14(24):3775–3786. https://doi.org/10.1093/hmg/ddi391
doi: 10.1093/hmg/ddi391 pubmed: 16330482 pmcid: 16330482
Rusconi L, Salvatoni L, Giudici L, Bertani I, Kilstrup-Nielsen C, Broccoli V, Landsberger N (2008) CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J Biol Chem 283(44):30101–30111. https://doi.org/10.1074/jbc.M804613200
doi: 10.1074/jbc.M804613200 pubmed: 18701457 pmcid: 18701457
Bahi-Buisson N, Bienvenu T (2012) CDKL5-related disorders: from clinical description to molecular genetics. Mol Syndromol 2(3-5):137–152
pubmed: 22670135 pmcid: 22670135
Fehr S, Downs J, Ho G, de Klerk N, Forbes D, Christodoulou J, Williams S, Leonard H (2016) Functional abilities in children and adults with the CDKL5 disorder. Am J Med Genet A 170(11):2860–2869. https://doi.org/10.1002/ajmg.a.37851
doi: 10.1002/ajmg.a.37851 pubmed: 27528505 pmcid: 27528505
Fehr S, Wong K, Chin R, Williams S, de Klerk N, Forbes D, Krishnaraj R, Christodoulou J et al (2016) Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder. Neurology 87(21):2206–2213. https://doi.org/10.1212/WNL.0000000000003352
doi: 10.1212/WNL.0000000000003352 pubmed: 27770071 pmcid: 27770071
Neupauerova J, Sterbova K, Vlckova M, Sebronova V, Marikova T, Krutova M, David S, Krsek P et al (2017) Two novel variants affecting CDKL5 transcript associated with epileptic encephalopathy. Genet Test Mol Biomarkers 21(10):613–618. https://doi.org/10.1089/gtmb.2017.0110
doi: 10.1089/gtmb.2017.0110 pubmed: 28872899 pmcid: 28872899
Kilstrup-Nielsen C, Rusconi L, La Montanara P, Ciceri D, Bergo A, Bedogni F, Landsberger N (2012) What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy. Neural Plast 2012:728267. https://doi.org/10.1155/2012/728267
doi: 10.1155/2012/728267 pubmed: 22779007 pmcid: 22779007
Amendola E, Zhan Y, Mattucci C, Castroflorio E, Calcagno E, Fuchs C, Lonetti G, Silingardi D et al (2014) Mapping pathological phenotypes in a mouse model of CDKL5 disorder. PLoS One 9(5):e91613. https://doi.org/10.1371/journal.pone.0091613
doi: 10.1371/journal.pone.0091613 pubmed: 24838000 pmcid: 24838000
Wang IT, Allen M, Goffin D, Zhu X, Fairless AH, Brodkin ES, Siegel SJ, Marsh ED et al (2012) Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice. Proc Natl Acad Sci U S A 109(52):21516–21521. https://doi.org/10.1073/pnas.1216988110
doi: 10.1073/pnas.1216988110 pubmed: 23236174 pmcid: 23236174
Tang S, Wang IJ, Yue C, Takano H, Terzic B, Pance K, Lee JY, Cui Y et al (2017) Loss of CDKL5 in glutamatergic neurons disrupts hippocampal microcircuitry and leads to memory impairment in mice. J Neurosci 37(31):7420–7437. https://doi.org/10.1523/JNEUROSCI.0539-17.2017
doi: 10.1523/JNEUROSCI.0539-17.2017 pubmed: 28674172 pmcid: 28674172
Okuda K, Takao K, Watanabe A, Miyakawa T, Mizuguchi M, Tanaka T (2018) Comprehensive behavioral analysis of the Cdkl5 knockout mice revealed significant enhancement in anxiety- and fear-related behaviors and impairment in both acquisition and long-term retention of spatial reference memory. PLoS One 13(4):e0196587. https://doi.org/10.1371/journal.pone.0196587
doi: 10.1371/journal.pone.0196587 pubmed: 29702698 pmcid: 29702698
Fuchs C, Gennaccaro L, Trazzi S, Bastianini S, Bettini S, Lo Martire V, Ren E, Medici G et al (2018) Heterozygous CDKL5 knockout female mice are a valuable animal model for CDKL5 disorder. Neural Plast 2018:9726950. https://doi.org/10.1155/2018/9726950
doi: 10.1155/2018/9726950 pubmed: 29977282 pmcid: 29977282
Fuchs C, Rimondini R, Viggiano R, Trazzi S, De Franceschi M, Bartesaghi R, Ciani E (2015) Inhibition of GSK3beta rescues hippocampal development and learning in a mouse model of CDKL5 disorder. Neurobiol Dis 82:298–310. https://doi.org/10.1016/j.nbd.2015.06.018
doi: 10.1016/j.nbd.2015.06.018 pubmed: 26143616 pmcid: 26143616
Della Sala G, Putignano E, Chelini G, Melani R, Calcagno E, Michele Ratto G, Amendola E, Gross CT et al (2016) Dendritic spine instability in a mouse model of CDKL5 disorder is rescued by insulin-like growth factor 1. Biol Psychiatry 80(4):302–311. https://doi.org/10.1016/j.biopsych.2015.08.028
doi: 10.1016/j.biopsych.2015.08.028 pubmed: 26452614 pmcid: 26452614
Ren E, Roncacé V, Trazzi S, Fuchs C, Medici G, Gennaccaro L, Loi M, Galvani G et al (2019) Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist. Front Cell Neurosci 13(169). https://doi.org/10.3389/fncel.2019.00169
Pizzo R, Gurgone A, Castroflorio E, Amendola E, Gross C, Sassoe-Pognetto M, Giustetto M (2016) Lack of Cdkl5 disrupts the organization of excitatory and inhibitory synapses and parvalbumin interneurons in the primary visual cortex. Front Cell Neurosci 10:261. https://doi.org/10.3389/fncel.2016.00261
doi: 10.3389/fncel.2016.00261 pubmed: 27965538 pmcid: 27965538
Ricciardi S, Ungaro F, Hambrock M, Rademacher N, Stefanelli G, Brambilla D, Sessa A, Magagnotti C et al (2012) CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. Nat Cell Biol 14(9):911–923. https://doi.org/10.1038/ncb2566
doi: 10.1038/ncb2566 pubmed: 22922712 pmcid: 22922712
Trazzi S, De Franceschi M, Fuchs C, Bastianini S, Viggiano R, Lupori L, Mazziotti R, Medici G et al (2018) CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder. Hum Mol Genet 27(9):1572–1592. https://doi.org/10.1093/hmg/ddy064
doi: 10.1093/hmg/ddy064 pubmed: 29474534 pmcid: 29474534
Zhu YC, Xiong ZQ (2019) Molecular and synaptic bases of CDKL5 disorder. Dev Neurobiol 79(1):8–19. https://doi.org/10.1002/dneu.22639
doi: 10.1002/dneu.22639 pubmed: 30246934 pmcid: 30246934
Fuchs C, Medici G, Trazzi S, Gennaccaro L, Galvani G, Berteotti C, Ren E, Loi M et al (2019) CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling. Brain Pathol. https://doi.org/10.1111/bpa.12716
Strober W (2015) Trypan blue exclusion test of cell viability. Curr Protoc Immunol 111:A3 B 1–A3 B 3. https://doi.org/10.1002/0471142735.ima03bs111
doi: 10.1002/0471142735.ima03bs111 pubmed: 26529666 pmcid: 26529666
Valli E, Trazzi S, Fuchs C, Erriquez D, Bartesaghi R, Perini G, Ciani E (2012) CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells. Biochim Biophys Acta 1819(11–12):1173–1185. https://doi.org/10.1016/j.bbagrm.2012.08.001
doi: 10.1016/j.bbagrm.2012.08.001 pubmed: 22921766 pmcid: 22921766
Takahashi T, Nowakowski RS, Caviness VS Jr (1993) Cell cycle parameters and patterns of nuclear movement in the neocortical proliferative zone of the fetal mouse. J Neurosci 13(2):820–833
doi: 10.1523/JNEUROSCI.13-02-00820.1993
Li Z, Lin H, Zhu Y, Wang M, Luo J (2001) Disruption of cell cycle kinetics and cyclin-dependent kinase system by ethanol in cultured cerebellar granule progenitors. Brain Res Dev Brain Res 132(1):47–58
doi: 10.1016/S0165-3806(01)00294-2
Fujita S (1967) Quantitative analysis of cell proliferation and differentiation in the cortex of the postnatal mouse cerebellum. J Cell Biol 32(2):277–287
doi: 10.1083/jcb.32.2.277
Contestabile A, Fila T, Bartesaghi R, Ciani E (2009) Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn mouse, an animal model for Down syndrome. Brain Pathol 19(2):224–237. https://doi.org/10.1111/j.1750-3639.2008.00168.x
doi: 10.1111/j.1750-3639.2008.00168.x pubmed: 18482164 pmcid: 18482164
Trazzi S, Fuchs C, Viggiano R, De Franceschi M, Valli E, Jedynak P, Hansen FK, Perini G et al (2016) HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder. Hum Mol Genet 25(18):3887–3907. https://doi.org/10.1093/hmg/ddw231
doi: 10.1093/hmg/ddw231 pubmed: 27466189 pmcid: 27466189
Contestabile A, Fila T, Cappellini A, Bartesaghi R, Ciani E (2009) Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. Cell Prolif 42(2):171–181. https://doi.org/10.1111/j.1365-2184.2009.00587.x
doi: 10.1111/j.1365-2184.2009.00587.x pubmed: 19317805 pmcid: 19317805
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
doi: 10.1016/0003-2697(76)90527-3
Wu G, Lu ZH, Wang J, Wang Y, Xie X, Meyenhofer MF, Ledeen RW (2005) Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1. J Neurosci 25(47):11014–11022. https://doi.org/10.1523/JNEUROSCI.3635-05.2005
doi: 10.1523/JNEUROSCI.3635-05.2005 pubmed: 16306414 pmcid: 16306414
Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, Bartesaghi R, Ciani E (2007) Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 17(8):665–678. https://doi.org/10.1002/hipo.20308
doi: 10.1002/hipo.20308 pubmed: 17546680 pmcid: 17546680
Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, Gallego C, Comella JX (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75(3):991–1003
doi: 10.1046/j.1471-4159.2000.0750991.x
Christensen J, Steain M, Slobedman B, Abendroth A (2011) Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells. J Virol 85(16):8436–8442. https://doi.org/10.1128/JVI.00515-11
doi: 10.1128/JVI.00515-11 pubmed: 21632750 pmcid: 21632750
Gimenez-Cassina A, Lim F, Diaz-Nido J (2006) Differentiation of a human neuroblastoma into neuron-like cells increases their susceptibility to transduction by herpesviral vectors. J Neurosci Res 84(4):755–767. https://doi.org/10.1002/jnr.20976
doi: 10.1002/jnr.20976 pubmed: 16802347 pmcid: 16802347
Shipley MM, Mangold CA, Kuny CV, Szpara ML (2017) Differentiated human SH-SY5Y cells provide a reductionist model of herpes simplex virus 1 neurotropism. J Virol 91(23). https://doi.org/10.1128/JVI.00958-17
Fuchs C, Trazzi S, Torricella R, Viggiano R, De Franceschi M, Amendola E, Gross C, Calza L et al (2014) Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3beta signaling. Neurobiol Dis 70:53–68. https://doi.org/10.1016/j.nbd.2014.06.006
doi: 10.1016/j.nbd.2014.06.006 pubmed: 24952363 pmcid: 24952363
Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ (1993) Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Neuron 11(2):321–331
doi: 10.1016/0896-6273(93)90187-V
Ferrari-Toninelli G, Bonini SA, Uberti D, Napolitano F, Stante M, Santoro F, Minopoli G, Zambrano N et al (2009) Notch activation induces neurite remodeling and functional modifications in SH-SY5Y neuronal cells. Dev Neurobiol 69(6):378–391. https://doi.org/10.1002/dneu.20710
doi: 10.1002/dneu.20710 pubmed: 19263417 pmcid: 19263417
Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF (2015) Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35(6):600–604. https://doi.org/10.3109/10799893.2015.1030412
doi: 10.3109/10799893.2015.1030412
Sanchez-Alegria K, Flores-Leon M, Avila-Munoz E, Rodriguez-Corona N, Arias C (2018) PI3K signaling in neurons: a central node for the control of multiple functions. Int J Mol Sci 19(12). https://doi.org/10.3390/ijms19123725
Fuchs C, Fustini N, Trazzi S, Gennaccaro L, Rimondini R, Ciani E (2018) Treatment with the GSK3-beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice. Eur J Neurosci 47(9):1054–1066. https://doi.org/10.1111/ejn.13923
doi: 10.1111/ejn.13923 pubmed: 29603837 pmcid: 29603837
Hendzel MJ, Wei Y, Mancini MA, Van Hooser A, Ranalli T, Brinkley BR, Bazett-Jones DP, Allis CD (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106(6):348–360
doi: 10.1007/s004120050256
Fielder E, von Zglinicki T, Jurk D (2017) The DNA damage response in neurons: die by apoptosis or survive in a senescence-like state? J Alzheimers Dis 60(s1):S107–S131. https://doi.org/10.3233/JAD-161221
doi: 10.3233/JAD-161221 pubmed: 28436392 pmcid: 28436392
Ji J, Zhang Y, Redon CE, Reinhold WC, Chen AP, Fogli LK, Holbeck SL, Parchment RE et al (2017) Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay. PLoS One 12(2):e0171582. https://doi.org/10.1371/journal.pone.0171582
doi: 10.1371/journal.pone.0171582 pubmed: 28158293 pmcid: 28158293
Podhorecka M, Skladanowski A, Bozko P (2010, 2010) H2AX phosphorylation: its role in DNA damage response and cancer therapy. J Nucleic Acids. https://doi.org/10.4061/2010/920161
Althaus FR, Richter C (1987) ADP-ribosylation of proteins. Enzymology and biological significance. Mol Biol Biochem Biophys 37:1–237
pubmed: 3118181 pmcid: 3118181
Cleaver JE, Morgan WF (1991) Poly(ADP-ribose)polymerase: a perplexing participant in cellular responses to DNA breakage. Mutat Res 257(1):1–18
doi: 10.1016/0165-1110(91)90016-O
Lindahl T, Satoh MS, Poirier GG, Klungland A (1995) Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20(10):405–411
doi: 10.1016/S0968-0004(00)89089-1
Rancourt A, Satoh MS (2009) Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage. DNA Repair (Amst) 8(3):286–297. https://doi.org/10.1016/j.dnarep.2008.11.018
doi: 10.1016/j.dnarep.2008.11.018
Meder VS, Boeglin M, de Murcia G, Schreiber V (2005) PARP-1 and PARP-2 interact with nucleophosmin/B23 and accumulate in transcriptionally active nucleoli. J Cell Sci 118(Pt 1):211–222. https://doi.org/10.1242/jcs.01606
doi: 10.1242/jcs.01606 pubmed: 15615785 pmcid: 15615785
Uutela M, Lindholm J, Rantamaki T, Umemori J, Hunter K, Voikar V, Castren ML (2014) Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome. Front Cell Neurosci 8:150. https://doi.org/10.3389/fncel.2014.00150
doi: 10.3389/fncel.2014.00150 pubmed: 24904293 pmcid: 24904293
Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2(6):1547–1558
doi: 10.1016/0896-6273(89)90043-3
Yang JL, Sykora P, Wilson DM 3rd, Mattson MP, Bohr VA (2011) The excitatory neurotransmitter glutamate stimulates DNA repair to increase neuronal resiliency. Mech Ageing Dev 132(8–9):405–411. https://doi.org/10.1016/j.mad.2011.06.005
doi: 10.1016/j.mad.2011.06.005 pubmed: 21729715 pmcid: 21729715
Narciso L, Parlanti E, Racaniello M, Simonelli V, Cardinale A, Merlo D, Dogliotti E (2016) The response to oxidative DNA damage in neurons: mechanisms and disease. Neural Plast 2016:3619274. https://doi.org/10.1155/2016/3619274
doi: 10.1155/2016/3619274 pubmed: 26942017 pmcid: 26942017
Altman BJ, Rathmell JC (2012) Metabolic stress in autophagy and cell death pathways. Cold Spring Harb Perspect Biol 4(9):a008763. https://doi.org/10.1101/cshperspect.a008763
doi: 10.1101/cshperspect.a008763 pubmed: 22952396 pmcid: 22952396
Liu J, Kim J, Oberdoerffer P (2013) Metabolic modulation of chromatin: implications for DNA repair and genomic integrity. Front Genet 4:182. https://doi.org/10.3389/fgene.2013.00182
doi: 10.3389/fgene.2013.00182 pubmed: 24065984 pmcid: 24065984
Chen Q, Zhu YC, Yu J, Miao S, Zheng J, Xu L, Zhou Y, Li D et al (2010) CDKL5, a protein associated with rett syndrome, regulates neuronal morphogenesis via Rac1 signaling. J Neurosci 30(38):12777–12786. https://doi.org/10.1523/JNEUROSCI.1102-10.2010
doi: 10.1523/JNEUROSCI.1102-10.2010 pubmed: 20861382 pmcid: 20861382
Luo J (2012) The role of GSK3beta in the development of the central nervous system. Front Biol 7(3):212–220. https://doi.org/10.1007/s11515-012-1222-2
doi: 10.1007/s11515-012-1222-2
Verma N, Franchitto M, Zonfrilli A, Cialfi S, Palermo R, Talora C (2019) DNA damage stress: cui prodest? Int J Mol Sci 20(5). https://doi.org/10.3390/ijms20051073
Wang JY (2001) DNA damage and apoptosis. Cell Death Differ 8(11):1047–1048. https://doi.org/10.1038/sj.cdd.4400938
doi: 10.1038/sj.cdd.4400938 pubmed: 11687882 pmcid: 11687882
Zinkel S, Gross A, Yang E (2006) BCL2 family in DNA damage and cell cycle control. Cell Death Differ 13(8):1351–1359. https://doi.org/10.1038/sj.cdd.4401987
doi: 10.1038/sj.cdd.4401987 pubmed: 16763616 pmcid: 16763616
Barbiero I, Valente D, Chandola C, Magi F, Bergo A, Monteonofrio L, Tramarin M, Fazzari M et al (2017) CDKL5 localizes at the centrosome and midbody and is required for faithful cell division. Sci Rep 7(1):6228. https://doi.org/10.1038/s41598-017-05875-z
doi: 10.1038/s41598-017-05875-z pubmed: 28740074 pmcid: 28740074
Enriquez-Rios V, Dumitrache LC, Downing SM, Li Y, Brown EJ, Russell HR, McKinnon PJ (2017) DNA-PKcs, ATM, and ATR interplay maintains genome integrity during neurogenesis. J Neurosci 37(4):893–905. https://doi.org/10.1523/JNEUROSCI.4213-15.2016
doi: 10.1523/JNEUROSCI.4213-15.2016 pubmed: 28123024 pmcid: 28123024
Kinoshita Y, Wenzel HJ, Kinoshita C, Schwartzkroin PA, Morrison RS (2012) Acute, but reversible, kainic acid-induced DNA damage in hippocampal CA1 pyramidal cells of p53-deficient mice. Epilepsia 53(Suppl 1):125–133. https://doi.org/10.1111/j.1528-1167.2012.03483.x
doi: 10.1111/j.1528-1167.2012.03483.x pubmed: 22612817 pmcid: 22612817
Youngsoo L, Inseo C, Jusik K, Keeeun K (2016) DNA damage to human genetic disorders with neurodevelopmental defects. J Genet Med 13(1):1–13
doi: 10.5734/JGM.2016.13.1.1
Markkanen E, Meyer U, Dianov GL (2016) DNA damage and repair in schizophrenia and autism: implications for cancer comorbidity and beyond. Int J Mol Sci 17(6). https://doi.org/10.3390/ijms17060856

Auteurs

Manuela Loi (M)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126, Bologna, Italy.

Stefania Trazzi (S)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126, Bologna, Italy. stefania.trazzi3@unibo.it.

Claudia Fuchs (C)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126, Bologna, Italy.

Giuseppe Galvani (G)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126, Bologna, Italy.

Giorgio Medici (G)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126, Bologna, Italy.

Laura Gennaccaro (L)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126, Bologna, Italy.

Marianna Tassinari (M)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126, Bologna, Italy.

Elisabetta Ciani (E)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Piazza di Porta San Donato 2, 40126, Bologna, Italy. elisabetta.ciani@unibo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH